Literature DB >> 16005189

The many faces of nitric oxide in schizophrenia. A review.

Hans-Gert Bernstein1, Bernhard Bogerts, Gerburg Keilhoff.   

Abstract

Intense research has been conducted in an effort to identify specific biological markers of schizophrenia. The gas nitric oxide (NO) is one of the most important signaling molecules involved in a plethora of cellular events that take place in the cardiovascular, immune and nervous systems of animals. This survey aims to demonstrate that NO and its metabolites play important roles in schizophrenia and have a significant influence on our understanding of the development, progression and treatment of the disease. Special emphasis is given to the impact of NO metabolism on processes known to be disturbed in schizophrenia (i.e., cell migration, formation of synapses, NMDA receptor mediated neurotransmission, membrane pathology and cognitive abilities). However, when comparing data on the NO metabolism in the brain tissue and body fluids of schizophrenics with those obtained from patients with other neurological and psychiatric diseases, it becomes clear that alterations of NO metabolism are not unique to, or indicative of, schizophrenia. Thus, NO and its metabolites are not suitable diagnostic tools to distinguish schizophrenia from psychically healthy control cases or from other brain disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005189     DOI: 10.1016/j.schres.2005.05.019

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  37 in total

1.  Epicatechin inhibits human plasma lipid peroxidation caused by haloperidol in vitro.

Authors:  Anna Dietrich-Muszalska; Bogdan Kontek; Beata Olas; Jolanta Rabe-Jabłońska
Journal:  Neurochem Res       Date:  2011-11-12       Impact factor: 3.996

2.  Morin Attenuates Neurochemical Changes and Increased Oxidative/Nitrergic Stress in Brains of Mice Exposed to Ketamine: Prevention and Reversal of Schizophrenia-Like Symptoms.

Authors:  Benneth Ben-Azu; Adegbuyi Oladele Aderibigbe; Aya-Ebi Okubo Eneni; Abayomi Mayowa Ajayi; Solomon Umukoro; Ezekiel O Iwalewa
Journal:  Neurochem Res       Date:  2018-06-28       Impact factor: 3.996

3.  Signaling Mechanisms in the Nitric Oxide Donor- and Amphetamine-Induced Dopamine Release in Mesencephalic Primary Cultured Neurons.

Authors:  Cristiane Salum; Fanny Schmidt; Patrick P Michel; Elaine Del-Bel; Rita Raisman-Vozari
Journal:  Neurotox Res       Date:  2015-09-21       Impact factor: 3.911

4.  Postmortem studies indicate altered cell chemical composition of the suprachiasmatic nucleus in mood disorders.

Authors:  Hans-Gert Bernstein; Bernhard Bogerts; Gerburg Keilhoff; Johann Steiner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-11-08       Impact factor: 5.270

5.  Role of oxidative stress in the pathophysiology of Toxoplasma gondii infection.

Authors:  Gungor Cagdas Dincel; Hasan Tarik Atmaca
Journal:  Int J Immunopathol Pharmacol       Date:  2016-03-10       Impact factor: 3.219

6.  Evidence for the contribution of NOS1 gene polymorphism (rs3782206) to prefrontal function in schizophrenia patients and healthy controls.

Authors:  Zhifang Zhang; Xiongying Chen; Ping Yu; Qiumei Zhang; Xiaochen Sun; Huang Gu; Hao Zhang; Jinguo Zhai; Min Chen; Boqi Du; Xiaoxiang Deng; Feng Ji; Chuanyue Wang; Yutao Xiang; Dawei Li; Hongjie Wu; Jun Li; Qi Dong; Chuansheng Chen
Journal:  Neuropsychopharmacology       Date:  2014-12-10       Impact factor: 7.853

Review 7.  Kidney-brain crosstalk in the acute and chronic setting.

Authors:  Renhua Lu; Matthew C Kiernan; Anne Murray; Mitchell H Rosner; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2015-08-18       Impact factor: 28.314

8.  S-nitrosylation of HDAC2 regulates the expression of the chromatin-remodeling factor Brm during radial neuron migration.

Authors:  Alexi Nott; Justyna Nitarska; Jesse V Veenvliet; Stephan Schacke; Alwin A H A Derijck; Piotr Sirko; Christian Muchardt; R Jeroen Pasterkamp; Marten P Smidt; Antonella Riccio
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

9.  Critical role of nitric oxide in the modulation of prepulse inhibition in Swiss mice.

Authors:  Ana C Issy; João Francisco C Pedrazzi; Bruno H Yoneyama; Elaine A Del-Bel
Journal:  Psychopharmacology (Berl)       Date:  2013-10-08       Impact factor: 4.530

10.  A placebo-controlled study of sildenafil effects on cognition in schizophrenia.

Authors:  Donald C Goff; Corinne Cather; Oliver Freudenreich; David C Henderson; A Eden Evins; Melissa A Culhane; Jared P Walsh
Journal:  Psychopharmacology (Berl)       Date:  2008-08-21       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.